Emergent Biosolutions Announces That Biothrax (Anthrax Vaccine Adsorbed) Receives Market Authorization In India
Biological E. of Hyderabad, India to serve as marketing agent for BioThrax in India
Emergent BioSolutions Inc. (NYSE: EBS) announced today that the Drugs Controller General of India (DCGI) has issued a registration certificate for BioThraxВ® (Anthrax Vaccine Adsorbed), which enables the marketing and sale of the vaccine in India to help prevent anthrax infection. Emergent [...]
July 13, 2009
Tags: Bacillus anthracis, Biothrax, Emergent BioSolutions, Form 10-Q, Government of India, India, Private Securities Litigation Reform Act, United States., US Food and Drug Administration. Posted in: Uncategorized 
No Comments